Trial · NCT07888946
OR Video-Laryngoscope Evaluations
NCT07888946, Not applicable, Active not recruiting, University of Colorado, Denver
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. OR Video-Laryngoscope Evaluations. Trials, record NCT07888946. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07888946
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- OR Video-Laryngoscope Evaluations
- NCT number
- NCT07888946
- Status
- Active not recruiting
- Phases
- Not applicable
- Enrollment
- 180 participants, estimated
- Lead sponsor
- University of Colorado, Denver
- Conditions
- Video Laryngoscopy, Quality Improvement, Operating Rooms, Comparative Effectiveness Study, Survey
- Interventions
- AMBU Product, CMAC-Storz, Glidescope
- First posted
- 2026-10-22
- Last updated
- 2026-10-27
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Global usability rating | 3 months | Likert-scale measurement (1-5) of global usability. Question is framed as: "what is your overall rating of this product?" 1. = Not globally usable at all 2. = Somewhat not globally usable 3. = Moderately globally usable 4. = Very globally usable 5. = Most globally usable |
| Secondary | Illumination and airway visualization | 3 months | Likert-scale outcomes (1-5 scale) assessed via survey of study physicians 1. = Poorest illumination and visibility 2. = Below-average illumination and visibility 3. = Average illumination and visibility 4. = Above-average illumination and visibility 5. = Best illumination and visibility |
| Secondary | Packaging and assembly | 3 months | Likert-scale outcomes (1-5 scale) assessed via survey of study physicians 1. = Poorest packaging and assembly 2. = Below-average packaging and assembly 3. = Average packaging and assembly 4. = Above-average packaging and assembly 5. = Best packaging and assembly |
| Secondary | Sturdiness and rigidity | 3 months | Likert-scale outcomes (1-5 scale) assessed via survey of study physicians 1. = Poorest sturdiness and rigidity 2. = Below-average sturdiness and rigidity 3. = Moderate sturdiness and rigidity 4. = Above-average sturdiness and rigidity 5. = Best sturdiness and rigidity |
| Secondary | Comfort and ease-of-use | 3 months | Likert-scale outcomes (1-5 scale) assessed via survey of study physicians 1. = Most uncomfortable and most difficult to use 2. = Very uncomfortable and very difficult to use 3. = Moderately comfortable and moderately easy to use 4. = Very comfortable and very easy to use 5. = Most comfortable and most easy to use |
| Secondary | Screen resolution | 3 months | Likert-scale outcomes (1-5 scale) assessed via survey of study physicians 1. = Poorest screen resolution 2. = Below-average screen resolution 3. = Moderate screen resolution 4. = Above-average screen resolution 5. = Best screen resolution |
| Secondary | Overall rating | 3 months | Likert-scale outcomes (1-5 scale) assessed via survey of study physicians 1. = Poorest-possible overall rating 2. = Below-average overall rating 3. = Moderate overall rating 4. = Above-average overall rating 5. = Best-possible overall rating |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 36627551 | BACKGROUND |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07888946
GET https://conductscience.org/api/trials/v1/NCT07888946/registered